• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[冠心病患者血脂亚组与冠状动脉狭窄程度的相关性研究]

[Study on the correlation between subgroup of blood lipid with degree of coronary artery stenosis in patients with coronary atherosclerotic heart disease].

作者信息

Wang X Y, Peng Y J, Han X J, Jia K G

机构信息

Clinical School of Cardiovascular Diseases, Tianjin Medical University, Tianjin 300457, China.

Department of Clinical Laboratory, Second People's Hospital of Yuhang District, Hangzhou 211121, China.

出版信息

Zhonghua Yu Fang Yi Xue Za Zhi. 2021 Dec 6;55(12):1435-1441. doi: 10.3760/cma.j.cn112150-20210519-00486.

DOI:10.3760/cma.j.cn112150-20210519-00486
PMID:34963240
Abstract

To study the correlation between low-density lipoprotein particles (LDL-P) with other lipoprotein indexes. To explore the correlation between LDL-P and its subgroup particles(LDL1-P-LDL6-P) with the degree of coronary artery stenosis in patients with coronary atherosclerotic heart disease(CHD) combining with the result of coronary arteriography. To explore the value of lipoprotein subgroup granules in preventing the severity of coronary artery stenosis in CHD patients. Cross-sectional study. A total of 259 patients without lipid-lowering drugs for coronary angiography in the department of cardiology of TEDA International Cardiovascular Hospital during 3 months from August 2019 to December 2019 were collected, and 52 healthy subjects were recruited during the same period. The level of high sensitivity C-reactive protein (hs-CRP) and other biochemical indexes were detected by automatic biochemical analyzer. The level of LDL-P and other biochemical indexes were detected by nuclear magnetic resonance spectroscopy(NMRS). The relation between various biomarkers levels with coronary artery stenosis degree was analyzed. Analysis of variance and nonparametric tests were used to compare the differences of indexes among each group. Pearson correlation analysis was used to determine the correlation among the measured indexes. Logistic regression was used for multi-factor analysis, ROC curve was used to evaluate the diagnostic value of related indexes. LDL-P was highly correlated with low-density lipoprotein cholesterol (LDL-C),apolipoprotein B (ApoB) and total cholesterol (TC) (= 0.927, <0.001; =0.921, <0.001; =0.844, <0.001). LDL-P, LDL4-P, LDL5-P and LDL6-P in patients with severe coronary stenosis were higher than those in patients with mild coronary stenosis(=4 172.000, =4.256, <0.001; =2.573, =0.011; =3 995.000, =4.621, <0.001;=5.223, <0.001), LDL-P and LDL6-P were higher than those of patients with moderate coronary stenosis (=1 159.000, =2.294, =0.022; =2.075, =0.041). High levels of hs-CRP, LDL5-P and LDL6-P were risk factors for the degree of coronary stenosis(=1.095, =0.036;=1.015, =0.046;=1.012, =0.039). ROC analysis showed that the AUC of LDL-P, LDL5-P and LDL6-P on coronary stenosis was 0.67, 0.68 and 0.69, respectively. Hs-CRP combined with LDL5-P and LDL6-P had the greatest effect on the degree of coronary stenosis (AUC= 0.70). LDL-P is highly correlated with LDL-C. The levels of LDL-P and LDL6-P were significantly higher in patients with severe stenosis than in patients with mild and moderate stenosis. hs-CRP, LDL5-P and LDL6-P can be used as new risk factors for the degree of coronary stenosis and may be further used as risk predictors. The combined detection of hs-CRP, LDL5-P and LDL6-P is helpful for the diagnosis of the severity of coronary stenosis, and may further become risk predictors.

摘要

研究低密度脂蛋白颗粒(LDL-P)与其他脂蛋白指标之间的相关性。结合冠状动脉造影结果,探讨LDL-P及其亚组颗粒(LDL1-P-LDL6-P)与冠状动脉粥样硬化性心脏病(CHD)患者冠状动脉狭窄程度之间的相关性。探讨脂蛋白亚组颗粒在预防CHD患者冠状动脉狭窄严重程度方面的价值。横断面研究。收集2019年8月至2019年12月3个月期间泰达国际心血管病医院心内科259例未服用降脂药物行冠状动脉造影的患者,并同期招募52例健康受试者。采用自动生化分析仪检测高敏C反应蛋白(hs-CRP)等生化指标水平。采用核磁共振波谱法(NMRS)检测LDL-P等生化指标水平。分析各生物标志物水平与冠状动脉狭窄程度的关系。采用方差分析和非参数检验比较各组指标差异。采用Pearson相关分析确定各测量指标之间的相关性。采用Logistic回归进行多因素分析,采用ROC曲线评估相关指标的诊断价值。LDL-P与低密度脂蛋白胆固醇(LDL-C)、载脂蛋白B(ApoB)和总胆固醇(TC)高度相关(r = 0.927,P < 0.001;r = 0.921,P < 0.001;r = 0.844,P < 0.001)。重度冠状动脉狭窄患者的LDL-P、LDL4-P、LDL5-P和LDL6-P高于轻度冠状动脉狭窄患者(F = 4172.000,P = 4.256,P < 0.001;t = 2.573,P = 0.011;F = 3995.000,P = 4.621,P < 0.001;t = 5.223,P < 0.001),LDL-P和LDL6-P高于中度冠状动脉狭窄患者(t = 1159.000,P = 2.294,P = 0.022;t = 2.075,P = 0.041)。hs-CRP、LDL5-P和LDL6-P水平升高是冠状动脉狭窄程度的危险因素(β = 1.095,P = 0.036;β = 1.015,P = 0.046;β = 1.012,P = 0.039)。ROC分析显示,LDL-P、LDL5-P和LDL6-P对冠状动脉狭窄的AUC分别为0.67·、0.68和0.69。Hs-CRP联合LDL5-P和LDL6-P对冠状动脉狭窄程度的影响最大(AUC = 0.70)。LDL-P与LDL-C高度相关。重度狭窄患者的LDL-P和LDL6-P水平显著高于轻度和中度狭窄患者。Hs-CRP、LDL5-P和LDL6-P可作为冠状动脉狭窄程度的新危险因素,可能进一步用作风险预测指标。Hs-CRP、LDL5-P和LDL6-P联合检测有助于诊断冠状动脉狭窄的严重程度,并可能进一步成为风险预测指标。

相似文献

1
[Study on the correlation between subgroup of blood lipid with degree of coronary artery stenosis in patients with coronary atherosclerotic heart disease].[冠心病患者血脂亚组与冠状动脉狭窄程度的相关性研究]
Zhonghua Yu Fang Yi Xue Za Zhi. 2021 Dec 6;55(12):1435-1441. doi: 10.3760/cma.j.cn112150-20210519-00486.
2
Association of plasma apolipoprotein CIII, high sensitivity C-reactive protein and tumor necrosis factor-α contributes to the clinical features of coronary heart disease in Li and Han ethnic groups in China.血浆载脂蛋白 CIII、高敏 C 反应蛋白和肿瘤坏死因子-α的相关性有助于中国汉族和黎族人群冠心病的临床特征。
Lipids Health Dis. 2018 Jul 27;17(1):176. doi: 10.1186/s12944-018-0830-5.
3
Particles and corrected particles of LDL and non-HDL are stronger predicters of coronary lesion in postmenopausal women.LDL 和非-HDL 的颗粒和修正颗粒是绝经后妇女冠状动脉病变的更强预测因子。
BMC Cardiovasc Disord. 2021 Aug 2;21(1):369. doi: 10.1186/s12872-021-02189-x.
4
The roles of a novel anti-inflammatory factor, milk fat globule-epidermal growth factor 8, in patients with coronary atherosclerotic heart disease.新型抗炎因子——乳脂肪球表皮生长因子 8 在冠心病患者中的作用。
Atherosclerosis. 2014 Apr;233(2):661-665. doi: 10.1016/j.atherosclerosis.2014.01.013. Epub 2014 Jan 22.
5
Correlations of degree of coronary artery stenosis with blood lipid, CRP, Hcy, GGT, SCD36 and fibrinogen levels in elderly patients with coronary heart disease.老年冠心病患者冠状动脉狭窄程度与血脂、CRP、Hcy、GGT、SCD36、纤维蛋白原水平的相关性。
Eur Rev Med Pharmacol Sci. 2019 Nov;23(21):9582-9589. doi: 10.26355/eurrev_201911_19453.
6
Assessment of Remnant Lipoprotein Cholesterol and Oxidized Low density Lipoprotein Associated with Low-grade Inflammation in Coronary Heart Disease Subjects of Young South Indian Population.评估南印度年轻人群冠心病患者的残余脂蛋白胆固醇和与低度炎症相关的氧化型低密度脂蛋白。
J Assoc Physicians India. 2022 Jun;70(6):11-12. doi: 10.5005/japi-11001-0009.
7
Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.依泽替米贝对低密度脂蛋白亚型分布的影响:一项在接受常规低密度脂蛋白去除法和他汀类药物治疗的患者中进行的安慰剂对照双盲试验结果
Metabolism. 2006 May;55(5):599-604. doi: 10.1016/j.metabol.2005.11.015.
8
Circulating Oxidized Low-Density Lipoprotein is a Strong Risk Factor for the Early Stage of Coronary Heart Disease.循环氧化型低密度脂蛋白是冠心病早期的一个强危险因素。
IUBMB Life. 2019 Feb;71(2):277-282. doi: 10.1002/iub.1966. Epub 2018 Nov 10.
9
[Relationship between serum levels of osteoproteins, inflammatory cytokines and coronary heart disease and disease severity].[血清骨蛋白、炎性细胞因子水平与冠心病及其疾病严重程度的关系]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 May;31(5):588-593. doi: 10.3760/cma.j.issn.2095-4352.2019.05.013.
10
Plasma neutrophil gelatinase-associated lipocalin levels are associated with the presence and severity of coronary heart disease.血浆中性粒细胞明胶酶相关脂质运载蛋白水平与冠心病的存在和严重程度相关。
PLoS One. 2019 Aug 6;14(8):e0220841. doi: 10.1371/journal.pone.0220841. eCollection 2019.

引用本文的文献

1
Banxia Gualou Xiebai Tang and Qishen Yiqi Dropping Pills Combined Therapy for Qi Deficiency, Phlegm, and Blood Stasis Syndrome in Post-PCI Coronary Heart Disease Patients.半夏瓜蒌薤白汤联合芪参益气滴丸治疗PCI术后冠心病气虚痰瘀证患者的疗效观察
Int J Gen Med. 2025 Mar 31;18:1795-1805. doi: 10.2147/IJGM.S510793. eCollection 2025.